BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 251,185,504
- Total 13F shares
- 174,435,511
- Share change
- +8,432,365
- Total reported value
- $1,308,746,834
- Put/Call ratio
- 68%
- Price per share
- $7.50
- Number of holders
- 273
- Value change
- +$63,398,447
- Number of buys
- 146
- Number of sells
- 89
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.4%
from 13D/G
|
22,095,163
|
$166,155,623 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
21,890,422
|
$164,615,973 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
13D/G
|
Company |
4.2%
from 13D/G
|
11,865,000
|
$89,224,800 | — | 31 Dec 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
3.6%
|
9,085,368
|
$68,321,967 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.2%
|
8,144,442
|
$61,246,204 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
7,498,967
|
$56,392,232 | — | 31 Dec 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
7,093,822
|
$53,345,541 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
4,823,735
|
$36,283,220 | — | 31 Dec 2024 | |
| RP Management, LLC |
13F
|
Company |
1.5%
|
3,846,154
|
$29,230,770 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.4%
|
3,419,046
|
$25,711,225 | — | 31 Dec 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.3%
|
3,182,617
|
$23,933,278 | — | 31 Dec 2024 | |
| Caligan Partners LP |
13F
|
Company |
1.2%
|
2,995,932
|
$22,529,409 | — | 31 Dec 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.2%
|
2,941,396
|
$22,119,000 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
2,677,996
|
$20,138,530 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1%
|
2,499,812
|
$18,798,586 | — | 31 Dec 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.83%
|
2,081,316
|
$15,651,499 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
2,004,911
|
$15,076,931 | — | 31 Dec 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.79%
|
1,980,312
|
$14,891,946 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
1,979,992
|
$14,889,540 | — | 31 Dec 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.73%
|
1,842,986
|
$13,859,254 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.71%
|
1,774,214
|
$13,342,089 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.68%
|
1,720,581
|
$12,938,769 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
1,665,732
|
$12,526,314 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,579,960
|
$11,881,299 | — | 31 Dec 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.57%
|
1,422,196
|
$10,694,914 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
1,384,633
|
$10,412,440 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
1,291,230
|
$9,710,049 | — | 31 Dec 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.47%
|
1,177,929
|
$8,858,026 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.43%
|
1,072,600
|
$8,065,952 | — | 31 Dec 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.39%
|
983,033
|
$7,392,408 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
899,838
|
$6,766,782 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
839,274
|
$6,311,343 | — | 31 Dec 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.33%
|
835,972
|
$6,286,509 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
800,000
|
$6,016,000 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.31%
|
790,105
|
$5,941,590 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.31%
|
777,268
|
$5,845,055 | — | 31 Dec 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.29%
|
725,305
|
$5,454,000 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.27%
|
667,000
|
$5,015,840 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.25%
|
633,864
|
$4,766,657 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
625,905
|
$4,706,805 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
596,938
|
$4,488,975 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.23%
|
572,346
|
$4,304,042 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.23%
|
565,215
|
$4,250,416 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
545,021
|
$4,098,558 | — | 31 Dec 2024 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.22%
|
542,100
|
$4,076,592 | — | 31 Dec 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
535,558
|
$4,027,396 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.21%
|
529,653
|
$3,982,991 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.21%
|
524,804
|
$3,946,526 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.21%
|
522,657
|
$3,935,607 | — | 31 Dec 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.21%
|
522,290
|
$3,927,621 | — | 31 Dec 2024 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q1 2025
As of 31 Mar 2025,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
273 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
174,435,511 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Kynam Capital Management, LP, Avoro Capital Advisors LLC, STATE STREET CORP, ALKEON CAPITAL MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GEODE CAPITAL MANAGEMENT, LLC, RP Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
273
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
256
Q1 2025 holders
273
Holder diff
17
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.